IRF1 and breast carcinoma: Bowie et al demonstrated that IRF-1 is critical for the promotion of p53-independent apoptosis in acutely damaged basal-type human mammary epithelial cells, providing evidence that loss of IRF-1 is a short-term marker of early basal-type breast cancer risk (59).